Monday morning saw 34 8-Ks and 6 shelf prospectuses filed; Theravance Biopharma leads with a multi-item event announcement.
Top 3
- Theravance Biopharma (CIK 1583107): 8-K filed 6:30am ET with items 1.01 (material agreement), 7.01 (regulation FD disclosure), 8.01 (financial statements), and 9.01 (exhibits); note that item 1.01 buries potential material agreement detail under filer item 2.01.
- Volato Group, Inc. (CIK 1853070): 8-K filed 6:03am ET reporting cost savings initiative (1.01) with cost reduction agreement details nested under item 5.02 (costs associated with exit).
- KORN FERRY (CIK 56679): 8-K filed 6:10am ET combining material agreement (1.01), creation of executive officer position (3.02), regulation FD disclosure (7.01), and exhibits (9.01); material agreement detail buried under item 2.01.
Paid subscribers see 7 more flagged filings + sector signals — upgrade for $9/mo
FilingFirehose Daily · 2026-06-29